|
US2013303973A1
|
|
Drug storage and delivery device and method
|
|
CN103189047A
|
|
Collagen-based implants for sustained delivery of drugs
|
|
CN103200983A
|
|
Device and method for the controlled delivery of ophthalmic solutions
|
|
KR20120114282A
|
|
Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema
|
|
JP2011063602A
|
|
Composition for stabilizing corneal tissue during or after orthokeratology lens wear
|
|
WO2011031948A2
|
|
Prevention of myopia
|
|
WO2010099102A1
|
|
Orthokeratology lens wear combined with chemical treatment to correct myopia, hyperopia or astigmatism
|
|
BRPI0909182A2
|
|
Uses of corneal epithelial junction disrupting agent, molecular bridge dissociating agent between stromal collagen fibers and stromal collagen mesh restoration agent
|
|
CN101969900A
|
|
Ultraviolet irradiation to treat corneal weakness disorders
|
|
EP2004209A2
|
|
Composition and method for stabilizing corneal tissue after refractive surgery
|
|
US2005231682A1
|
|
Composition for stabilizing corneal tissue during or after orthokeratology lens wear
|
